Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

DeepDyve requires Javascript to function. Please enable Javascript on your browser to continue.

How Is Money Changing Medicine?—Venture Capital Investment in Oncology

Huang, Kevin B.; Nambudiri, Vinod E.

JAMA Oncology , Volume 6 (3) – Mar 2, 2020

Read Article

Download PDF

Share Full Text for Free

2 pages

This Viewpoint discusses the potential and constraints of venture capital investment in oncology.

Loading next page...

References (4)

J. Kaiser (2018)
Too much of a good thing?
Science, 359 6382
Asher Mullard (2019)
2018 FDA drug approvals
Nature Reviews Drug Discovery, 18
LT Ratcliffe (2011)
A Venture Capital View of Challenges, Opportunities, and Innovation in Biomedical Research
Clinical Pharmacology & Therapeutics, 89
Jonathan Fleming (2015)
The decline of venture capital investment in early-stage life sciences poses a challenge to continued innovation.
Health affairs, 34 2

Publisher: American Medical Association
Copyright: Copyright 2020 American Medical Association. All Rights Reserved.
ISSN: 2374-2437
eISSN: 2374-2445
DOI: 10.1001/jamaoncol.2019.5348
Publisher site: See Article on Publisher Site

There are no references for this article.